Proteome analysis of Leishmania (Viannia) braziliensis by two-dimensional gel electrophoresis and mass spectrometry

Molecular and Biochemical Parasitology

Volumn 154, Issue 1, 2007, Pages 6-21

  Cuervo, Patricia ^a,b   de Jesus, Jose Batista ^a   Junqueira, Magno ^c   Mendonça Lima, Leila ^a   González, Luis Javier ^d   Betancourt, Lázaro ^d   Grimaldi Jr , Gabriel ^a   Domont, Gilberto Barbosa ^c   Fernandes, Octavio ^a   Cupolillo, Elisa ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Leishmania (V.) braziliensis; Leishmania braziliensis 2D reference map; Leishmaniasis; Mass spectrometry; Proteome

Indexed keywords

ARTICLE; LEISHMANIA BRAZILIENSIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ISOELECTRIC POINT; LEISHMANIA BRAZILIENSIS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTOZOAN PROTEINS;

LEISHMANIA BRAZILIENSIS; MAMMALIA; PROTOZOA;

EID: 34250216750     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2007.03.013     Document Type: Article

References (69)

1. Grimaldi Jr. G., and Tesh R.B. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 6 (1993) 230-250
2. Saravia N., Holguín A., McMahon-Pratt D., and D'Alessandro A. Mucocutaneous Leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 34 (1985) 714-720
3. Marsden P.D. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 80 (1986) 859-876
4. Weigle K.A., Saravia N.G., de Davalos M., Moreno L.H., and D'Alessandro A. Leishmania braziliensis from the Pacific coast region of Colombia: foci of transmission, clinical spectrum and isoenzyme phenotypes. Am J Trop Med Hyg 35 (1986) 722-731
5. Saravia N.G., Segura I., Holguin A.F., Santrich C., Valderrama L., and Ocampo C. Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia. Am J Trop Med Hyg 59 (1998) 86-94
6. Cupolillo E., Grimaldi Jr. G., and Momen H. A general classification of New World Leishmania using numerical zymotaxonomy. Am J Trop Med Hyg 50 (1994) 296-311
7. Cupolillo E., Brahim L.R., Toaldo C.B., et al. Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil. J Clin Microbiol 41 (2003) 3126-3132
8. McMahon-Pratt D., Jaffe C.L., Bennett E., David J.R., and Grimaldi Jr. G. Studies employing monoclonal antibodies for the analysis of the genus Leishmania Ross, 1903. Leishmania Taxonomie et Phylogenese Applications Eco-épidemiologiques Montpellier (1986), IMEEE, France p. 173-8
9. Grimaldi Jr. G., David J.R., and McMahon-Pratt D. Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. Am J Trop Med Hyg 36 (1987) 270-287
10. Grimaldi Jr. G., Momen H., Naiff R.D., and McMahon-Pratt D. Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil. Am J Trop Med Hyg 44 (1991) 645-661
11. Saravia N.G., Weigle K., Navas C., et al. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia. Am J Trop Med Hyg 66 (2002) 738-744
12. Cuervo P., Saboia-Vahia L., Costa Silva-Filho F., Fernandes O., Cupolillo E., and DE Jesus J.B. A zymographic study of metalloprotease activities in extracts and extracellular secretions of Leishmania (Viannia) braziliensis strains. Parasitology 132 (2006) 177-185
13. Ivens A.C., Peacock C.S., Worthey E.A., et al. The genome of the kinetoplastid parasite, Leishmania major. Science 309 (2005) 436-442
14. Acestor N., Masina S., Walker J., Saravia N.G., Fasel N., and Quadroni M. Establishing two-dimensional gels for the analysis of Leishmania proteomes. Proteomics 2 (2002) 877-879
15. Gongora R., Acestor N., Quadroni M., Fasel N., Saravia N.G., and Walker J. Mapping the proteome of Leishmania Viannia parasites using two-dimensional polyacrylamide gel electrophoresis and associated technologies. Biomedica 23 (2003) 153-160
16. Drummelsmith J., Brochu V., Girard I., Messier N., and Ouellette M. Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol Cell Proteomics 2 (2003) 146-155
17. El Fakhry Y., Ouellette M., and Papadopoulou B. A proteomic approach to identify developmentally regulated proteins in Leishmania infantum. Proteomics 2 (2002) 1007-1017
18. Bente M., Harder S., Wiesgigl M., et al. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics 3 (2003) 1811-1829
19. Nugent P.G., Karsani S.A., Wait R., Tempero J., and Smith D.F. Proteomic analysis of Leishmania mexicana differentiation. Mol Biochem Parasitol 136 (2004) 51-62
20. Walker J., Vasquez J.J., Gomez M.A., et al. Identification of developmentally-regulated proteins in Leishmania panamensis by proteome profiling of promastigotes and axenic amastigotes. Mol Biochem Parasitol 147 (2006) 64-73
21. McNicoll F., Drummelsmith J., Muller M., et al. A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics 6 (2006) 3567-3581
22. Walker J., Acestor N., Gongora R., et al. Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis. Mol Biochem Parasitol 145 (2006) 254-264
23. Vergnes B., Gourbal B., Girard I., et al. A proteomic screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6 (2007) 88-101
24. Laurentino E.C., Ruiz J.C., Fazelinia G., et al. A survey of Leishmania braziliensis genome by shotgun sequencing. Mol Biochem Parasitol 137 (2004) 81-86
25. Neuhoff V., Arold N., Taube D., and Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9 (1988) 255-262
26. Shevchenko A., Sunyaev S., Loboda A., Bork P., Ens W., and Standing K.G. Charting the proteomes of organisms with unsequenced genomes by MALDI-quadrupole time-of-flight mass spectrometry and BLAST homology searching. Anal Chem 73 (2001) 1917-1926
27. Liska A.J., and Shevchenko A. Expanding the organismal scope of proteomics: cross-species protein identification by mass spectrometry and its implications. Proteomics 3 (2003) 19-28
28. Huang P.L., Roberts B.E., Pratt D.M., David J.R., and Miller J.S. Structure and arrangement of the beta-tubulin genes of Leishmania tropica. Mol Cell Biol 4 (1984) 1372-1383
29. Jackson A.P., Vaughan S., and Gull K. Comparative genomics and concerted evolution of beta-tubulin paralogs in Leishmania spp. BMC Genomics 7 137 (2006) 10.1186/1471-2164-7-137
30. Mendoza-Leon A., Havercroft J.C., and Barker D.C. The RFLP analysis of the beta-tubulin gene region in New World Leishmania. Parasitology 111 (1995) 1-9
31. Cupolillo E., Grimaldi Jr. G., Momen H., and Beverley S.M. Intergenic region typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania. Mol Biochem Parasitol 73 (1995) 145-155
32. Hunt D.F., Yates III J.R., Shabanowitz J., Winston S., and Hauer C.R. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci 83 (1986) 6233-6237
33. Atwood III J.A., Weatherly D.B., Minning T.A., et al. The Trypanosoma cruzi proteome. Science 309 (2005) 473-476
34. Thiede B., Lamer S., Mattow J., et al. Analysis of missed cleavage sites, tryptophan oxidation and N-terminal pyroglutamylation after in-gel tryptic digestion. Rapid Commun Mass Spectrom 14 (2000) 496-502
35. Shevchenko A., Loboda A., Ens W., Schraven B., Standing K.G., and Shevchenko A. Archived polyacrylamide gels as a resource for proteome characterization by mass spectrometry. Electrophoresis 22 (2001) 1194-1203
36. Polevoda B., and Sherman F. Nα-terminal acetylation of eukaryotic proteins. J Biol Chem 275 (2000) 36479-36482
37. Abe A., Saeki K., Yasunaga T., and Wakabayashi T. Acetylation at the N-terminus of actin strengthens weak interaction between actin and myosin. Biochem Biophys Res Commun 268 (2000) 14-19
38. Groll M., Heinemeyer W., Jager S., et al. The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc Natl Acad Sci USA 96 (1999) 10976-10983
39. Cummins P.M., and O'Connor B. Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim Biophys Acta 1429 (1998) 1-17
40. Blaszczyk J., Coillie E.V., Proost P., et al. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry 39 (2000) 14075-14081
41. Robinson N.E., and Robinson A.B. Molecular clocks. Proc Natl Acad Sci USA 98 (2001) 944-949
42. Weintraub S.J., and Manson S.R. Asparagine deamidation: a regulatory hourglass. Mech Age Dev 125 (2004) 255-257
43. Brochu C., Haimeur A., and Ouellette M. The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania. Cell Stress Chaperones 9 (2004) 294-303
44. Achour Y.B., Chenik M., Louzir H., and Dellagi K. Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor. Infect Immun 70 (2002) 3576-3585
45. Dea-Ayuela M.A., Rama-Iniguez S., and Bolas-Fernandez F. Proteomic analysis of antigens from Leishmania infantum promastigotes. Proteomics 6 (2006) 4187-4194
46. Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc-finger protein R1-associated nuclear localization. Biosci Biotech Biochem 66 (2002) 1-21
47. Nandan D., Yi T., Lopez M., Lai C., and Reiner N.E. Leishmania EF-1α activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophages deactivation. J Biol Chem 277 (2002) 50190-50197
48. Vickers T.J., Wylie S.H., and Fairlamb A.H. Leishmania major elongation factor 1B complex has trypanothione S-transferase and peroxidase activity. J Biol Chem 279 (2004) 49003-49009
49. de Diego J.L., Katz J.M., Marshall P., et al. The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochemistry 40 (2001) 1053-1062
50. Silva-Jardim I., Horta M.F., and Ramalho-Pinto F.J. The Leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages. Acta Trop 91 (2004) 121-130
51. Descoteaux A., and Turco S.J. Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta 1455 (1999) 341-352
52. Mottram J.C., Brooks D.R., and Coombs G.H. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr Opin Microbiol 1 (1998) 455-460
53. Mottram J.C., Coombs G.H., and Alexander J. Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 7 (2004) 375-381
54. Salotra P., Duncan R.C., Singh R., et al. Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis. Microbes Infect 8 (2006) 637-644
55. Schmidt A., and Krauth-Siegel R.L. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development. Curr Top Med Chem 2 (2002) 1239-1259
56. Henderson D.M., Hanson S., Allen T., et al. Cloning of the gene encoding Leishmania donovani S-adenosylhomocysteine hydrolase, a potential target for antiparasitic chemotherapy. Mol Biochem Parasitol 53 (1992) 169-183
57. Olliaro P., and Wirth D. New targets for antimalarial drug discovery. J Pharm Pharmacol 49 (1997) 29-33
58. Heikkila T., Thirumalairajan S., Davies M., et al. The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorg Med Chem Lett 16 (2006) 88-92
59. Jutel M., Watanabe T., Klunker S., et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413 (2001) 420-425
60. Pós Z., Muller K., Novalphak I., et al. Different patterns of the L-histidine decarboxylase (HDC) gene expression in mice resistant and susceptible to experimental cutaneous leishmaniasis. Inflamm Res 53 (2004) 38-43
61. Lezama-Davila C.M., Isaac-Marquez A.P., Padierna-Olivos J., Aguilar-Torrentera F., and Chapa-Ruiz R. Immunomodulation of Chiclero's ulcer. Role of eosinophils, T cells, tumour necrosis factor and interleukin-2. Scand J Immunol 47 (1998) 502-508
62. Badolato R., Sacks D.L., Savoia D., and Musso T. Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Exp Parasitol 82 (1996) 21-26
63. MacDonald S.M., Bhisutthibhan J., Shapiro T.A., et al. Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homologue in vitro and in vivo. Proc Natl Acad Sci USA 98 (2001) 10829-10832
64. Prelich G., Tan C.K., Kostura M., et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326 (1987) 517-520
65. Bravo R., Frank R., Blundell P.A., and Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326 (1987) 515-517
66. Mottram J.C., Kinnaird J., Shiels B.R., Tait A., and Barry J.D. A novel CDC2-related protein kinase from Leishmania mexicana, lmm-CRK1, is post-translationally regulated during the life-cycle. J Biol Chem 268 (1993) 21044-21051
67. Grant K.M., Dunion M.H., Yardley V., et al. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity. Antimicrob Agents Chemother 48 (2004) 3033-3042
68. Schriefer A., Schriefer A.L., Goes-Neto A., et al. Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis. Infect Immun 72 (2004) 508-514
69. Leifso K., Cohen-Freue G., Murray A., Dogra N., and McMaster W.R. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Mol Biochem Parasitol 152 (2007) 35-46